Empresa Rhythm Pharmaceuticals, Inc.
Acciones
RYTM
US76243J1051
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
40,17 USD | +3,48 % | +0,68 % | -12,40 % |
Resumen de negocios
Número de empleados: 226
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 24 | 100,0 % | 77 | 100,0 % | +227,56 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
80,6
%
| 24 | 100,0 % | 62 | 80,6 % | +164,09 % |
Other
11,5
%
| - | - | 9 | 11,5 % | - |
Germany
7,8
%
| - | - | 6 | 7,8 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 01/11/15 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 01/07/17 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 27/07/20 |
Dana Washburn
CTO | Chief Tech/Sci/R&D Officer | 61 | 26/09/22 |
David Connolly
IRC | Investor Relations Contact | - | 01/05/19 |
Comptroller/Controller/Auditor | 53 | 01/03/23 | |
Corporate Officer/Principal | - | 01/04/21 | |
Pamela Cramer
HRO | Human Resources Officer | 50 | 26/07/21 |
Jim Flaherty
LAW | General Counsel | - | 01/07/19 |
Yann Mazabraud
PRN | Corporate Officer/Principal | 51 | 05/10/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 01/04/15 |
Jennifer Good
BRD | Director/Board Member | 59 | 19/06/19 |
David McGirr
BRD | Director/Board Member | 69 | 01/11/15 |
Director/Board Member | 71 | 09/12/20 | |
Director/Board Member | 64 | 21/03/13 | |
David Meeker
CEO | Chief Executive Officer | 69 | 01/11/15 |
Lynn Tetrault
BRD | Director/Board Member | 61 | 09/12/20 |
Stuart Arbuckle
BRD | Director/Board Member | 58 | 24/07/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 60 972 909 | 57 367 172 ( 94,09 %) | 0 | 94,09 % |
Información de la empresa
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street 12th floor
02116-3748, Boston
+857 264 4280
http://www.rhythmtx.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-12,40 % | 2366,97 M | |
-3,13 % | 102 mil M | |
+1,43 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,73 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,45 % | 16,36 mil M | |
+5,10 % | 13,97 mil M | |
+32,43 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción RYTM
- Empresa Rhythm Pharmaceuticals, Inc.